+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dipeptide Peptidase 4 Inhibitors Market by Type, by Application, by Distribution Channel, and By Region

  • PDF Icon

    Report

  • 200 Pages
  • March 2024
  • Region: Global
  • Erevna Healthcare
  • ID: 5941898
The global dipeptide peptidase 4 inhibitors market size was estimated to be USD 11.47 billion in 2023 and is expected to reach USD 15.81 billion by 2034 with a CAGR of 2.96% during the forecast period 2024-2034. The rising prevalence of type 2 diabetes, enhanced efficacy and tolerability, expanding applications, increased awareness and adoption, rising technological advancements, and government initiatives and support will drive the market growth.

Diabetes, especially type 2, affects millions of people globally and is a serious global health problem. An increasing number of people need efficient diabetes treatment methods due to the condition's rising incidence, which is fueled by factors including obesity, sedentary lifestyles, and aging populations. DPP-4 inhibitors are a popular choice among patients and medical professionals since they provide a secure and efficient means of regulating blood sugar levels. For instance, Boehringer Ingelheim and Eli Lilly will introduce a novel combination medicine containing metformin and linagliptin in September 2023 to enhance glucose management.

By type, the sitagliptin segment accounted for the highest revenue-grossing segment in the global dipeptide peptidase 4 inhibitors market in 2023 owing to the compound's widespread adoption as a first-line treatment for type 2 diabetes, its established efficacy in glycemic control, and its favorable safety profile. For instance, in August 2023, the FDA approved Novartis's Galvus extended-release pills, which provide the convenience of a once-daily dosage. Additionally, the alogliptin segment is predicted to grow at the fastest CAGR during the forecast period owing to the drug's unique pharmacological characteristics, increasing research and development activities, and a growing recognition of its efficacy in glycemic control.

By application, the type 2 diabetes segment accounted for the highest revenue-grossing segment in the global dipeptide peptidase 4 inhibitors market in 2023 owing to the escalating prevalence of type 2 diabetes worldwide, the increasing adoption of DPP-4 inhibitors as a preferred oral treatment option, and the growing emphasis on personalized and effective management strategies for individuals with type 2 diabetes. For instance, in July 2023, AstraZeneca and Merck & Co. will work together on a research project to create next-generation DPP-4 inhibitors with longer half-lives. Additionally, the gestational diabetes segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing awareness of gestational diabetes, rising maternal age, and a growing emphasis on maternal and fetal health.

By distribution channel, the retail pharmacies segment accounted for the highest revenue-grossing segment in the global dipeptide peptidase 4 inhibitors market in 2023 owing to the widespread accessibility and convenience offered by retail outlets, facilitating easy procurement of medications for patients with diabetes. For instance, in October 2023, GSK presented studies at a diabetes conference that suggested better cardiovascular outcomes might result from taking a DPP-4 inhibitor in addition to another diabetic medicine. Additionally, the online channels segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing trend of digitalization in healthcare, the convenience of online purchasing, and the expanding e-commerce infrastructure.

North American region is anticipated to have the highest revenue share during the forecast period owing to the well-established healthcare infrastructure, a high prevalence of diabetes, increasing awareness about diabetes management, and the early adoption of advanced therapeutic options. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the increasing prevalence of diabetes, rising awareness about diabetes management, improving healthcare infrastructure, and a growing focus on preventive healthcare measures. For instance, in September 2023, Daiichi Sankyo announced a collaboration with a medical device firm to create a combination treatment that combines Evogliptin with an implanted insulin pump for improved diabetes control.

This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.

Report Scope:

  • Base Year: 2023
  • Forecast Period: 2024-2034
  • Study Coverage
  • Market Forecast by Type, Application, and Distribution Channel
  • Market Forecast for 5 Regions and 17+ Countries
  • North America (U.S. and Canada)
  • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA (South Africa, GCC, Rest of MEA)
  • Exhaustive Company Profiles of the Top 10+ Major Market Players
  • 20% Free Customization Available to Meet Your Exact Requirement.

Segmentation: Dipeptide Peptidase 4 Inhibitors Market Report 2023 - 2034

Dipeptide Peptidase 4 Inhibitors Market Analysis & Forecast by Type 2023 - 2034 (Revenue USD Bn)

  • Sitagliptin
  • Saxagliptin
  • Linagliptin
  • Alogliptin
  • Vildagliptin
  • Others DPP-4 inhibitors

Dipeptide Peptidase 4 Inhibitors Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)

  • Type 2 Diabetes
  • Gestational Diabetes
  • Metabolic Syndrome
  • Others

Dipeptide Peptidase 4 Inhibitors Market Analysis & Forecast by Distribution Channel 2023 - 2034 (Revenue USD Bn)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Channels

Dipeptide Peptidase 4 Inhibitors Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
  • Middle East & Africa
  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Assumptions
1.4. Research Framework
2. Introduction
2.1. Market Definition
2.2. Global Dipeptide Peptidase 4 Inhibitors Market Overview
3. Executive Summary
4. Market Environment Analysis
4.1. Porter’s 5 Forces Analysis
4.2. PESTEL Analysis
4.3. SWOT Analysis
5. Market Dynamics
5.1. Drivers Analysis
5.2. Restraints Analysis
5.3. Opportunities Analysis
5.4. Threats Analysis
5.5. Trend Analysis
6. COVID-19 Impact Analysis
7. Dipeptide Peptidase 4 Inhibitors Market: Type Estimates & Trend Analysis
7.1. Type Segment Opportunity Analysis
7.2. Sitagliptin
7.2.1. Sitagliptin Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.3. Saxagliptin
7.3.1. Saxagliptin Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.4. Linagliptin
7.4.1. Linagliptin Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.5. Alogliptin
7.5.1. Alogliptin Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.6. Vildagliptin
7.6.1. Vildagliptin Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.7. Others DPP-4 inhibitors
7.7.1. Others DPP-4 inhibitors Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8. Dipeptide Peptidase 4 Inhibitors Market: Application Estimates & Trend Analysis
8.1. Application Segment Opportunity Analysis
8.2. Type 2 Diabetes
8.2.1. Type 2 Diabetes Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.3. Gestational Diabetes
8.3.1. Gestational Diabetes Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.4. Metabolic Syndrome
8.4.1. Metabolic Syndrome Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.5. Others
8.5.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9. Dipeptide Peptidase 4 Inhibitors Market: Distribution Channel Estimates & Trend Analysis
9.1. Distribution Channel Segment Opportunity Analysis
9.2. Hospital Pharmacies
9.2.1. Hospital Pharmacies Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.3. Retail Pharmacies
9.3.1. Retail Pharmacies Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.4. Online Channels
9.4.1. Online Channels Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10. Regional Market Analysis
10.1. Regional Market Opportunity Analysis
11. North America Dipeptide Peptidase 4 Inhibitors Market
11.1. North America Dipeptide Peptidase 4 Inhibitors Market
11.1.1. North America Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.1.2. North America Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
11.1.3. North America Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
11.1.4. North America Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
11.1.5. North America Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
11.2. U.S. Global Dipeptide Peptidase 4 Inhibitors Market
11.2.1. U.S. Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.2.2. U.S. Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
11.2.3. U.S. Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
11.2.4. U.S. Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
11.3. Canada Global Dipeptide Peptidase 4 Inhibitors Market
11.3.1. Canada Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.3.2. Canada Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
11.3.3. Canada Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
11.3.4. Canada Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12. Europe Global Dipeptide Peptidase 4 Inhibitors Market
12.1. Europe Global Dipeptide Peptidase 4 Inhibitors Market
12.1.1. Europe Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.1.2. Europe Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
12.1.3. Europe Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
12.1.4. Europe Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.1.5. Europe Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.2. Germany Global Dipeptide Peptidase 4 Inhibitors Market
12.2.1. Germany Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.2.2. Germany Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
12.2.3. Germany Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.2.4. Germany Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.3. UK Global Dipeptide Peptidase 4 Inhibitors Market
12.3.1. UK Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.3.2. UK Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
12.3.3. UK Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.3.4. UK Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.4. France Global Dipeptide Peptidase 4 Inhibitors Market
12.4.1. France Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.4.2. France Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
12.4.3. France Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.4.4. France Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.5. Spain Global Dipeptide Peptidase 4 Inhibitors Market
12.5.1. Spain Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.5.2. Spain Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
12.5.3. Spain Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.5.4. Spain Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.6. Italy Global Dipeptide Peptidase 4 Inhibitors Market
12.6.1. Italy Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.6.2. Italy Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
12.6.3. Italy Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.6.4. Italy Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.7. Rest of Europe Global Dipeptide Peptidase 4 Inhibitors Market
12.7.1. Rest of Europe Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.7.2. Rest of Europe Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
12.7.3. Rest of Europe Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.7.4. Rest of Europe Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13. Asia Pacific Global Dipeptide Peptidase 4 Inhibitors Market
13.1. Asia Pacific Global Dipeptide Peptidase 4 Inhibitors Market
13.1.1. Asia Pacific Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.1.2. Asia Pacific Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
13.1.3. Asia Pacific Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
13.1.4. Asia Pacific Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.1.5. Asia Pacific Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.2. Japan Global Dipeptide Peptidase 4 Inhibitors Market
13.2.1. Japan Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.2.2. Japan Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
13.2.3. Japan Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.2.4. Japan Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.3. China Global Dipeptide Peptidase 4 Inhibitors Market
13.3.1. China Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.3.2. China Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
13.3.3. China Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.3.4. China Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.4. India Global Dipeptide Peptidase 4 Inhibitors Market
13.4.1. India Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.4.2. India Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
13.4.3. India Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.4.4. India Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.5. South Korea Global Dipeptide Peptidase 4 Inhibitors Market
13.5.1. South Korea Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.5.2. South Korea Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
13.5.3. South Korea Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.5.4. South Korea Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.6. Australia Global Dipeptide Peptidase 4 Inhibitors Market
13.6.1. Australia Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.6.2. Australia Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
13.6.3. Australia Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.6.4. Australia Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.7. Rest of Asia Pacific Global Dipeptide Peptidase 4 Inhibitors Market
13.7.1. Rest of Asia Pacific Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.7.2. Rest of Asia Pacific Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
13.7.3. Rest of Asia Pacific Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.7.4. Rest of Asia Pacific Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14. Latin America Global Dipeptide Peptidase 4 Inhibitors Market
14.1. Latin America Global Dipeptide Peptidase 4 Inhibitors Market
14.1.1. Latin America Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.1.2. Latin America Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
14.1.3. Latin America Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
14.1.4. Latin America Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
14.1.5. Latin America Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.2. Brazil Global Dipeptide Peptidase 4 Inhibitors Market
14.2.1. Brazil Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.2.2. Brazil Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
14.2.3. Brazil Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
14.2.4. Brazil Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.3. Mexico Global Dipeptide Peptidase 4 Inhibitors Market
14.3.1. Mexico Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.3.2. Mexico Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
14.3.3. Mexico Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
14.3.4. Mexico Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.4. Argentina Global Dipeptide Peptidase 4 Inhibitors Market
14.4.1. Argentina Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.4.2. Argentina Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
14.4.3. Argentina Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
14.4.4. Argentina Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.5. Rest of Latin America Global Dipeptide Peptidase 4 Inhibitors Market
14.5.1. Rest of Latin America Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.5.2. Rest of Latin America Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
14.5.3. Rest of Latin America Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
14.5.4. Rest of Latin America Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15. MEA Global Dipeptide Peptidase 4 Inhibitors Market
15.1. MEA Global Dipeptide Peptidase 4 Inhibitors Market
15.1.1. MEA Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.1.2. MEA Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
15.1.3. MEA Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
15.1.4. MEA Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
15.1.5. MEA Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15.2. GCC Global Dipeptide Peptidase 4 Inhibitors Market
15.2.1. GCC Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.2.2. GCC Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
15.2.3. GCC Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
15.2.4. GCC Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15.3. South Africa Global Dipeptide Peptidase 4 Inhibitors Market
15.3.1. South Africa Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.3.2. South Africa Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
15.3.3. South Africa Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
15.3.4. South Africa Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15.4. Rest of MEA Global Dipeptide Peptidase 4 Inhibitors Market
15.4.1. Rest of MEA Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.4.2. Rest of MEA Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Type, 2023-2034 (Revenue USD Bn)
15.4.3. Rest of MEA Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
15.4.4. Rest of MEA Dipeptide Peptidase 4 Inhibitors Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
16. Competitor Analysis
16.1. Company Market Share Analysis, 2023
16.2. Major Recent Developments
17. Company Profiles
17.1. Merck & Co., Inc.
17.2. Novartis International AG
17.3. AstraZeneca plc
17.4. Takeda Pharmaceutical Company Limited
17.5. Boehringer Ingelheim International GmbH
17.6. Eli Lilly and Company
17.7. Bristol Myers Squibb Company
17.8. Pfizer Inc.
17.9. Sanofi S.A.
17.10. Johnson & Johnson
17.11. GlaxoSmithKline plc
17.12. Daiichi Sankyo Company, Limited
17.13. Sun Pharmaceutical Industries Ltd.
17.14. Hanmi Pharmaceutical Co., Ltd.
17.15. Jiangsu Hengrui Medicine Co., Ltd.
18. Conclusion19. Recommendations

Companies Mentioned

  • Merck & Co. Inc.
  • Novartis International AG
  • AstraZeneca plc
  • Takeda Pharmaceutical Company Limited
  • Boehringer Ingelheim International GmbH
  • Eli Lilly and Company
  • Bristol Myers Squibb Company
  • Pfizer Inc.
  • Sanofi S.A.
  • Johnson & Johnson
  • GlaxoSmithKline plc
  • Daiichi Sankyo Company
  • Limited
  • Sun Pharmaceutical Industries Ltd.
  • Hanmi Pharmaceutical Co. Ltd.
  • Jiangsu Hengrui Medicine Co. Ltd.

Table Information